【lhsaa first team all-district 2023】Helius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in November
NEWTOWN,lhsaa first team all-district 2023 Pa., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:
HSDT
) (TSX:
HSM
) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that management will participate in the following upcoming investor conferences:
The Investor Summit Group’s Virtual Fall Summit, which is being held from November 16th - 18th.
Management will present on Tuesday, November 17th at 1:00 p.m. Eastern Time.
Alliance Global Partners’ Virtual Healthcare Symposium, which is being held on November 19th.
Management will participate in virtual 1x1 meetings on Thursday, November 19th. There will be no formal presentation.
The
Sidoti
& Co. Virtual Fall Microcap Conference, which is being held on November 19th.
Management will present on Thursday, November 19th at 9:15 a.m. Eastern Time.
Live audio webcasts of the presentations will be provided under the ‘Events’ section of the Helius Medical Technologies investor relations website at
https://heliusmedical.com/index.php/investor-relations/events/upcoming-events
. Archives of the webcasts will be available for replay following the conference.
About Helius Medical Technologies, Inc.
Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS
TM
). For more information, visit
www.heliusmedical.com
.
About the PoNS™ Device and PoNS Treatment™
The Portable Neuromodulation Stimulator (PoNS™) is authorized for sale in Canada as a class II, non-implantable, medical device intended as a short term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from multiple sclerosis (MS), and chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI) and is to be used in conjunction with physical therapy. The PoNS™ is an investigational medical device in the United States, the European Union (“EU”), and Australia (“AUS”). The device is currently under review for clearance by the FDA. It is also under premarket review by the AUS Therapeutic Goods Administration. PoNS™ is currently not commercially available in the United States, the European Union or Australia.
Investor Relations Contact
:
Westwicke Partners on behalf of Helius Medical Technologies, Inc.
Mike Piccinino, CFA
View comments
-
Apple Tells Staff U.S. Stores to Remain Closed Until Early MayWhy You Should Like Industria de Diseño Textil, S.A.’s (BME:ITX) ROCEWhat Should Investors Know About TKH Group N.V.’s (AMS:TWEKA) Growth?BRIEF-Qingdao Huijintong Power Equipment Wins State Grid's Bids For 218.0 Million YuanIs Wanda Sports Group (WSG) A Good Stock To Buy Now?Cullen/Frost Bankers Ends 2018 With a BangTrade Alert: The Independent Director Of Continental Resources, Inc. (NYSE:CLR), Timothy Taylor, Has Just Spent US$101k Buying 14% More SharesAlex Jones Tells Joe Rogan: George Soros Offered Me $5 Million to Pump BitcoinTo the millions of parents who didn’t choose to homeschool: This is a unique opportunityYellowbrick Real Estate Changes Management; Announces Two Exciting Programs
下一篇:Why Uranium Markets Are Gaining Interest
- ·Mitch Gould and Nutritional Products International Welcome Record-Shattering GDP for Third Quarter
- ·BRIEF-Sunshine 100 China Posts January Contracted Sales Of RMB299 Mln
- ·Here's where Democratic Rep. Maxine Waters stands on raising taxes on the rich
- ·Prison Gerrymandering
- ·Romios Completes 2020 Field Work in the Golden Triangle, Identifies Strong Alteration Zones at Recent Copper-Gold Discoveries on its TREK SOUTH and ANDREI EAST Porphyry Targets
- ·Why Bank of America (BAC) Could Beat Earnings Estimates Again
- ·SoftBank Is Said to Prep Latam Fund Run by COO Claure
- ·How Does Totens Sparebank (OB:TOTG) Fare As A Dividend Stock?
- ·EU’s Digital Services Act Advocates Speak Up
- ·Why P&G (PG) Could Beat Earnings Estimates Again
- ·Amazon's Earnings Were Strong, but Its Outlook Disappointed: 5 Metrics You Should See
- ·GLOBAL MARKETS-World stocks nurse a New Year's hangover as growth worries persist
- ·Harpoon Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
- ·BRIEF-Hainan Airlines' Controlling Shareholder Renews Share Pledge
- ·The Winchesters star Bianca Kajlich talks ditching Millie's coveralls to join a hunt
- ·Bitcoin Blasts Past $34K for First Time, Hours After Blowing Through $30K
- ·Coronavirus strands merchant ship crews at sea for months
- ·Do Its Financials Have Any Role To Play In Driving Boston Scientific Corporation's (NYSE:BSX) Stock Up Recently?
- ·Evaluating New Times Energy Corporation Limited’s (HKG:166) Investments In Its Business
- ·The State of Medical Marijuana Is at a Crossroads in Florida
- ·Natural Gas Price Fundamental Weekly Forecast – Heating Season Begins with Hedge Funds Holding Long Positions
- ·How Should Investors Think About High Yield Bond Allocations?
- ·CenterPoint Energy (NYSE:CNP) Is Increasing Its Dividend To US$0.17
- ·BRIEF-Jiangsu Etern's Controlling Shareholder To Unload Up To 3 Pct Stake Between March 4 And Aug 30
- ·Is G5 Entertainment AB (publ)'s (STO:G5EN) Latest Stock Performance A Reflection Of Its Financial Health?
- ·3 Myths About Public Service Loan Forgiveness for Physicians
- ·Huawei confident it will supply core network technology to European operators
- ·Out-of-State Firms Continue Philly Hiring to Bulk Up Target Practices
- ·Your Daily Driver as a Three-Time Le Mans Champion
- ·Acclaris to Host Webinar on How to Engage and Support a Millennial Workforce
- ·SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses to Contact the Firm
- ·Budget 2019: Modi just attempted a surgical strike to retain power
- ·Traders: Bitcoin Trend Looking Ugly, Why a Slow Drop Below $3,000 is Expected
- ·BRIEF-Eastern Gold Jade's Chairman Zhao Ning Resigns After Company Expects Net Loss For 2018
- ·Is Now The Time To Look At Buying National Beverage Corp. (NASDAQ:FIZZ)?
- ·Morning News Call - U.S., January 2